Related Articles
Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment in patients with metastatic breast cancer
Efficacy of lapatinib combined with capecitabine in patients with HER2‑positive metastatic breast cancer in a real‑world study
Metronomic chemotherapy for metastatic breast cancer to prolong time to treatment failure to 12 months or more
Maintenance immunotherapy in metastatic breast cancer
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status